» Articles » PMID: 12453418

MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Nov 28
PMID 12453418
Citations 490
Authors
Affiliations
Soon will be listed here.
Abstract

MLL, the human homolog of Drosophila trithorax, maintains Hox gene expression in mammalian embryos and is rearranged in human leukemias resulting in Hox gene deregulation. How MLL or MLL fusion proteins regulate gene expression remains obscure. We show that MLL regulates target Hox gene expression through direct binding to promoter sequences. We further show that the MLL SET domain is a histone H3 lysine 4-specific methyltransferase whose activity is stimulated with acetylated H3 peptides. This methylase activity is associated with Hox gene activation and H3 (Lys4) methylation at cis-regulatory sequences in vivo. A leukemogenic MLL fusion protein that activates Hox expression had no effect on histone methylation, suggesting a distinct mechanism for gene regulation by MLL and MLL fusion proteins.

Citing Articles

YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma.

Warmke L, Ameline B, Fritchie K, Dehner C, Agaimy A, Ud Din N Virchows Arch. 2024; .

PMID: 39641785 DOI: 10.1007/s00428-024-03995-2.


HOXC12 promotes the invasion and migration of gastric cancer cells by upregulating SALL4 and activating Wnt/β-catenin signaling pathway.

Zhang J, Hou N, Rao D, Chen Q, Ning Z, Lu M Discov Oncol. 2024; 15(1):620.

PMID: 39500780 PMC: 11538222. DOI: 10.1007/s12672-024-01502-2.


Molecular diagnosis of patients with syndromic short stature identified by trio whole-exome sequencing.

Sun H, Zhang G, Li N, Bu X Front Genet. 2024; 15:1399186.

PMID: 39415983 PMC: 11479978. DOI: 10.3389/fgene.2024.1399186.


Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation.

Ogino J, Dou Y J Biol Chem. 2024; 300(10):107791.

PMID: 39303915 PMC: 11736124. DOI: 10.1016/j.jbc.2024.107791.


Drug Repurposing Approach to Identify Candidate Drug Molecules for Hepatocellular Carcinoma.

Baser T, Rifaioglu A, Atalay M, Cetin Atalay R Int J Mol Sci. 2024; 25(17).

PMID: 39273340 PMC: 11395636. DOI: 10.3390/ijms25179392.